These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2662741)

  • 1. Prehospital use of APSAC: results of a placebo-controlled study.
    Castaigne AD; Hervé C; Duval-Moulin AM; Gaillard M; Dubois-Rande JL; Boesch C; Wolf M; Lellouche D; Jan F; Vernant P
    Am J Cardiol; 1989 Jul; 64(2):30A-33A; discussion 41A-42A. PubMed ID: 2662741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehospital administration of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Castaigne AD; Duval AM; Dubois-Rande JL; Herve C; Jan F; Louvard Y
    Drugs; 1987; 33 Suppl 3():231-4. PubMed ID: 3315600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitation of myocardial infarct size and preservation of left ventricular function by early administration of APSAC in myocardial infarction.
    Bassand JP; Machecourt J; Cassagnes J; Lusson JR; Borel E; Schiele F
    Am J Cardiol; 1989 Jul; 64(2):18A-23A; discussion 24A-26A. PubMed ID: 2662738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised placebo-controlled pilot dose-response study with anisoylated plasminogen streptokinase activator complex in acute coronary artery occlusions.
    Leizorovicz A; Durrieu G; Boissel JP
    Drugs; 1987; 33 Suppl 3():133-7. PubMed ID: 3315579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML; Quilliet L; Kulbertus H; Materne P; Letac B; Cribier A; Monassier JP; Sacrez A; Favier JP
    Drugs; 1987; 33 Suppl 3():140-5. PubMed ID: 3315581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ
    Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study.
    Timmis AD; Griffin B; Crick JC; Sowton E
    J Am Coll Cardiol; 1987 Jul; 10(1):205-10. PubMed ID: 3298360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
    Johnson ES; Cregeen RJ
    Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ
    Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F
    Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
    Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Bossaert LL; Demey HE; Colemont LJ; Beaucourt L; Fierens H; Dirix L; Pintens H
    Crit Care Med; 1988 Sep; 16(9):823-30. PubMed ID: 3042284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion, patency and reocclusion with anistreplase (APSAC) in acute myocardial infarction.
    Anderson JL
    Am J Cardiol; 1989 Jul; 64(2):12A-17A; discussion 24A-26A. PubMed ID: 2662737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G; Charbonnier B
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction.
    Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW; Norry EC
    Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.
    Julian DG; Borthwick LS; Reid D; Jennings KP; Wainwright RJ; Rodger JC; Wood D; Phillips WS
    Drugs; 1987; 33 Suppl 3():261-7. PubMed ID: 3315604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.
    Lancet; 1988 Mar; 1(8585):545-9. PubMed ID: 2894490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction.
    Col JJ; Col-De Beys CM; Renkin JP; Lavenne-Pardonge EM; Bachy JL; Moriau MH
    Am J Cardiol; 1989 May; 63(17):1185-92. PubMed ID: 2653017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic assessment of patency and reocclusion: preliminary results of the Dutch APSAC Reocclusion Multicenter Study (ARMS).
    Visser RF
    Clin Cardiol; 1990 Mar; Suppl 5():V45-7; discussion V67-72. PubMed ID: 2182241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.